{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:34:38Z","timestamp":1787632478693,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T00:00:00Z","timestamp":1540684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Region Sk\u00e5ne, Sweden"},{"DOI":"10.13039\/100009678","name":"Scandinavian Society for Antimicrobial Therapy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009678","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Probi AB, Lund, Sweden"},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2209-4","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T09:59:37Z","timestamp":1540547977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Can probiotics be an alternative to chlorhexidine for oral care in the mechanically ventilated patient? A multicentre, prospective, randomised controlled open trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3531-8188","authenticated-orcid":false,"given":"Bengt","family":"Klarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Adolfsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Torstensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,28]]},"reference":[{"key":"2209_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/664049","volume":"33","author":"MH Kollef","year":"2012","unstructured":"Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012;33:250\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2209_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2047-2994-2-13","volume":"2","author":"R Leistner","year":"2013","unstructured":"Leistner R, Kankura L, Bloch A, Sohr D, Gastmeier P, Geffers C. Attributable costs of ventilator-associated lower respiratory tract infection (LRTI) acquired on intensive care units: a retrospectively matched cohort study. Antimicrob Resist Infect Control. 2013;2:13.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2209_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1378\/chest.13-0853","volume":"144","author":"J Muscedere","year":"2013","unstructured":"Muscedere J, Sinuff T, Heyland DK, Dodek PM, Keenan SP, Wood G, et al. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013;144:1453\u201360.","journal-title":"Chest"},{"key":"2209_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/CCM.0b013e31822d7913","volume":"40","author":"LP Skrupky","year":"2012","unstructured":"Skrupky LP, McConnell K, John Dallas J, Kollef MH. A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med. 2012;40:281\u20134.","journal-title":"Crit Care Med"},{"key":"2209_CR5","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00134-016-4303-x","volume":"42","author":"J Zeng","year":"2016","unstructured":"Zeng J, Wang C-T, Zhang F-S, et al. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med. 2016;42:1018\u201328.","journal-title":"Intensive Care Med"},{"key":"2209_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jhin.2003.06.001","volume":"57","author":"J-L Vincent","year":"2004","unstructured":"Vincent J-L. Ventilator-associated pneumonia. J Hosp Infection. 2004;57:272\u201380.","journal-title":"J Hosp Infection"},{"key":"2209_CR7","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4187\/respcare.05492","volume":"62","author":"A Rouz\u00e9","year":"2017","unstructured":"Rouz\u00e9 A, Jaillette E, Poissy J, Pr\u00e9au S, Nseir S. Tracheal tube design and ventilator-associated pneumonia. Respir Care. 2017;62:1316\u201323.","journal-title":"Respir Care"},{"key":"2209_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajic.2015.12.020","volume":"44","author":"K Speck","year":"2016","unstructured":"Speck K, Rawat N, Weiner NC, Tujuba HG, Farley D, Sean Berenholtz S. A systematic approach for developing a ventilator-associated pneumonia prevention bundle. Am J Infect Control. 2016;44:652\u20136.","journal-title":"Am J Infect Control"},{"key":"2209_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(03)14409-1","volume":"362","author":"E de Jonge","year":"2003","unstructured":"de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PMM, Vroom MB, Dankert J, Kesecioglu J. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet. 2003;362:1011\u20136.","journal-title":"Lancet"},{"key":"2209_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa0800394","volume":"360","author":"AMGA de Smet","year":"2009","unstructured":"de Smet AMGA, Kluytmans JAJW, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360:20\u201331.","journal-title":"N Engl J Med"},{"key":"2209_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/bmj.39136.528160.BE","volume":"334","author":"EY Chan","year":"2007","unstructured":"Chan EY, Ruest A, O Meade M, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. Br Med J. 2007;334:889\u201399.","journal-title":"Br Med J"},{"key":"2209_CR12","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.2147\/DDDT.S84587","volume":"9","author":"JS Di Zhao","year":"2015","unstructured":"Di Zhao JS, Gao X, Gao F, Wu Y, Lu Y, Hou K. Selective oropharyngeal decontamination versus selective digestive decontamination in critically ill patients: a meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2015;9:3617\u201324.","journal-title":"Drug Des Devel Ther"},{"key":"2209_CR13","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1136\/bmj.g2197","volume":"348","author":"R Price","year":"2014","unstructured":"Price R, MacLennan G, John Glen J. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. Br Med J. 2014;348:2197\u2013211.","journal-title":"Br Med J"},{"key":"2209_CR14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/jac\/dku092","volume":"69","author":"E Buelow","year":"2014","unstructured":"Buelow E, Bello Gonz\u00e1lez T, Verslius D. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother. 2014;69:2215\u201323.","journal-title":"J Antimicrob Chemother"},{"key":"2209_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40168-017-0309-z","volume":"5","author":"E Buelow","year":"2017","unstructured":"Buelow E, Bello Gonz\u00e1lez TDJ, Fuentes S, et al. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome. 2017;5:88.","journal-title":"Microbiome"},{"key":"2209_CR16","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1128\/AAC.02634-12","volume":"57","author":"T Halaby","year":"2013","unstructured":"Halaby T, al Naiemi N, Jan Kluytmans J, van der Palen J, Vandenbroucke-Graulsb CMJE. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57:3224\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2209_CR17","unstructured":"Schultz MJ, Haas LE. Last-line antibiotics are failing. European Centre for Disease Prevention and Control 18 Nov 2016. https:\/\/ecdc.europa.eu\/en\/news-events\/last-line-antibiotics-are-failing . Accessed 8 Oct 2018."},{"key":"2209_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1164\/rccm.200505-820OC","volume":"173","author":"M Koeman","year":"2006","unstructured":"Koeman M, Andre J, van der Ven AM, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2006;173:1348\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"2209_CR19","first-page":"CD008367","volume":"10","author":"F Hua","year":"2016","unstructured":"Hua F, Xie H, Worthington HV, Furness S, Zhang Q, Li C. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev. 2016;10:CD008367.","journal-title":"Cochrane Database Syst Rev"},{"key":"2209_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/sj.ebd.6401272","volume":"18","author":"A Veitz-Keenan","year":"2017","unstructured":"Veitz-Keenan A, Ferraiolo DM. Oral care with chlorhexidine seems effective for reducing the incidence of ventilator-associated pneumonia. Evidence-Based Dentistry. 2017;18:113\u20134.","journal-title":"Evidence-Based Dentistry"},{"key":"2209_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.pathol.2017.05.008","volume":"49","author":"C Hughes","year":"2017","unstructured":"Hughes C, Ferguson J. Phenotypic chlorhexidine and triclosan susceptibility in clinical Staphylococcus aureus isolates in Australia. Pathology. 2017;49:633\u20137.","journal-title":"Pathology"},{"key":"2209_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/bja\/aev050","volume":"114","author":"MS Opstrup","year":"2015","unstructured":"Opstrup MS, Johansen JD, Garvey LH. Chlorhexidine allergy: sources of exposure in the health-care setting. Br J Anaesth. 2015;114:705\u20136.","journal-title":"Br J Anaesth"},{"key":"2209_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ans.13269","volume":"86","author":"G Sharp","year":"2016","unstructured":"Sharp G, Green S, Rose M. Chlorhexidine-induced anaphylaxis in surgical patients: a review of the literature. ANZ J Surg. 2016;86:237\u201343.","journal-title":"ANZ J Surg"},{"key":"2209_CR24","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1128\/AEM.62.7.2244-2251.1996","volume":"62","author":"I Adlerberth","year":"1996","unstructured":"Adlerberth I, Ahrn\u00e9 S, Johansson M-L, Molin G, Hansson L\u00c5, Wold AE. A mannose-specific adherence mechanism in Lactobacillus plantarum conferring to the human colonic cell line HT-29. Appl Environ Microbiol. 1996;62:2244\u201351.","journal-title":"Appl Environ Microbiol"},{"key":"2209_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AEM.59.1.15-20.1993","volume":"59","author":"M-L Johansson","year":"1993","unstructured":"Johansson M-L, Molin G, Jeppsson B, Nobaek S, Ahrn\u00e9 S, Bengmark S. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol. 1993;59:15\u201320.","journal-title":"Appl Environ Microbiol"},{"key":"2209_CR26","doi-asserted-by":"publisher","first-page":"R285","DOI":"10.1186\/cc3522","volume":"9","author":"B Klarin","year":"2005","unstructured":"Klarin B, Johansson M-L, Molin G, Larsson A, Jeppsson B. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care. 2005;9:R285\u201393.","journal-title":"Crit Care"},{"issue":"Suppl 543","key":"2209_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/000164800454422","volume":"6","author":"A Stjernquist-Desatnik","year":"2000","unstructured":"Stjernquist-Desatnik A, Warfving H, Johansson M-L. Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel. Acta Otolaryngol. 2000;6(Suppl 543):215\u20139.","journal-title":"Acta Otolaryngol"},{"key":"2209_CR28","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/cc7109","volume":"12","author":"B Klarin","year":"2008","unstructured":"Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care. 2008;12:R136.","journal-title":"Crit Care"},{"key":"2209_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1472-765X.1995.tb01030.x","volume":"21","author":"M-L Johansson","year":"1995","unstructured":"Johansson M-L, Quednau M, Molin G, Ahrn\u00e9 S. Randomly amplified polymorphic DNA (RAPD) for rapid typing of Lactobacillus plantarum strains. Lett Appl Microbiol. 1995;21:155\u20139.","journal-title":"Lett Appl Microbiol"},{"key":"2209_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00394-010-0127-6","volume":"50","author":"A Berggren","year":"2011","unstructured":"Berggren A, Lazou A\u2019n I, Larsson N, \u00d6nning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2011;50:203\u201310.","journal-title":"Eur J Nutr"},{"key":"2209_CR31","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/jama.297.14.1583","volume":"297","author":"M Klompas","year":"2007","unstructured":"Klompas M. Does this patient have ventilator-associated pneumonia? JAMA. 2007;297:1583\u201393.","journal-title":"JAMA"},{"key":"2209_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00134-016-4217-7","volume":"42","author":"NL Plantinga","year":"2016","unstructured":"Plantinga NL, Wittekamp BHJ, Leleu K, Depuydt P, Van den Abeele A-M, Christian Brun-Buisson C, Bonten MJM. Oral mucosal adverse events with chlorhexidine 2% mouthwash in ICU. Intensive Care Med. 2016;42:620\u20131.","journal-title":"Intensive Care Med"},{"key":"2209_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/0030-4220(89)90321-6","volume":"67","author":"FKL Spijkervet","year":"1989","unstructured":"Spijkervet FKL, van Saene HKF, Panders AK, Vermey A, van Saene JJM, Mehta DM, Fidler V. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg Oral Med Oral Pathol. 1989;67:154\u201361.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2209_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","volume":"13","author":"WG Melsen","year":"2013","unstructured":"Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13:665\u201371.","journal-title":"Lancet Infect Dis"},{"key":"2209_CR35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.chemphyslip.2010.03.007","volume":"163","author":"I Komljenovic","year":"2010","unstructured":"Komljenovic I, Marquardt D, Harroun TA, Sternin E. Location of chlorhexidine in DMPC model membranes: a neutron diffraction study. Chem Phys Lipids. 2010;163:480\u20137.","journal-title":"Chem Phys Lipids"},{"key":"2209_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jamainternmed.2014.359","volume":"174","author":"M Klompas","year":"2014","unstructured":"Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systemic review and meta-analysis. JAMA Intern Med. 2014;174:751\u201361.","journal-title":"JAMA Intern Med"},{"key":"2209_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1055\/s-0037-1602584","volume":"38","author":"M Klompas","year":"2017","unstructured":"Klompas M. Oropharyngeal decontamination with antiseptics to prevent ventilator-associated pneumonia: rethinking the benefits of chlorhexidine. Semin Respir Crit Care Med. 2017;38:381\u201390.","journal-title":"Semin Respir Crit Care Med"},{"key":"2209_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bdj.2012.1086","volume":"213","author":"MN Pemberton","year":"2012","unstructured":"Pemberton MN, Gibson J. Chlorhexidine and hypersensitivity reactions in dentistry. Br Dental J. 2012;213:547.","journal-title":"Br Dental J"},{"key":"2209_CR39","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1399-6576.2008.01748.x","volume":"52","author":"B Klarin","year":"2008","unstructured":"Klarin B, Wullt M, Palmquist I, Molin G, Larsson A, Jeppsson B. Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiol Scand. 2008;52:1096\u2013102.","journal-title":"Acta Anaesthesiol Scand"},{"key":"2209_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00134-010-2002-6","volume":"37","author":"GJ Oudhuis","year":"2011","unstructured":"Oudhuis GJ, Bergmans DC, Dormans T, Zwaveling J-H, Kessels A, Prins MH Stobberingh EE, Verbon A. Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med. 2011;37:110\u20137.","journal-title":"Intensive Care Med"},{"key":"2209_CR41","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1046\/j.1365-2168.2002.02189.x","volume":"89","author":"A Ol\u00e1h","year":"2002","unstructured":"Ol\u00e1h A, Bel\u00e1gyi T, Issekutz \u00c1, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103\u20137.","journal-title":"Br J Surg"},{"key":"2209_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00007890-200207150-00021","volume":"74","author":"N Rayes","year":"2002","unstructured":"Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, Bengmark S, Neuhaus P. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74:123\u20138.","journal-title":"Transplantation"},{"key":"2209_CR43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0899-9007(02)00811-0","volume":"18","author":"N Rayes","year":"2002","unstructured":"Rayes N, Hansen S, Seehofer D, M\u00fcller AR, Serke S, Bengmark S, Neuhaus P. Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002;18:609\u201315.","journal-title":"Nutrition"},{"key":"2209_CR44","doi-asserted-by":"publisher","first-page":"e00642","DOI":"10.1002\/mbo3.642","volume":"24","author":"B Klarin","year":"2018","unstructured":"Klarin B, Larsson A, Molin G, Jeppsson B. Susceptibility to antibiotics in isolates of Lactobacillus plantarum RAPD-type Lp299v, harvested from antibiotic treated, critically ill patients after administration of probiotics. Microbiology. 2018;24:e00642. https:\/\/doi.org\/10.1002\/mbo3.642 [Epub ahead of print].","journal-title":"Microbiology"},{"issue":"S2","key":"2209_CR45","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1093\/cid\/civ085","volume":"60","author":"S Doron","year":"2015","unstructured":"Doron S, Snydman DR. Risk and safety of probiotics. Clin Inf Diseases. 2015;60(S2):S129\u201334.","journal-title":"Clin Inf Diseases"},{"key":"2209_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1164\/rccm.200912-1853OC","volume":"182","author":"LE Morrow","year":"2010","unstructured":"Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182:1058\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"2209_CR47","first-page":"805","volume":"80","author":"L Silvestri","year":"2014","unstructured":"Silvestri L, Weir I, Gregori D, Taylor N, Zandstra DF, Van Saene JJM, Van Saene HKF. Effectiveness of oral chlorhexidine on nosocomial pneumonia, causative micro-organisms and mortality in critically ill patients: a systematic review and meta-analysis. Minerva. 2014;80:805.","journal-title":"Minerva"},{"key":"2209_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13054-016-1434-y","volume":"20","author":"W Manzanares","year":"2016","unstructured":"Manzanares W, Margot Lemieux M, Langlois PI, Wischmeyer PE. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 2016;20:262.","journal-title":"Crit Care"},{"key":"2209_CR49","first-page":"CD009066","volume":"10","author":"L Bo","year":"2014","unstructured":"Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, Kollef MH, Crooks NH, Deng X. Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014;10:CD009066.","journal-title":"Cochrane Database Syst Rev"},{"key":"2209_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1378\/chest.12-1745","volume":"143","author":"D Barraud","year":"2013","unstructured":"Barraud D, Bollaert P-E, Gibot S. Impact of the administration of probiotics on mortality in critically ill adult patients. A meta-analysis of randomized controlled trials. Chest. 2013;143:646\u201355.","journal-title":"Chest"},{"key":"2209_CR51","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00134-018-5171-3","volume":"44","author":"M Deschepper","year":"2018","unstructured":"Deschepper M, Waegeman W, Eeckloo K, Vogelaers D, Blot S. Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide observational cohort study. Intensive Care Med. 2018;44:1017\u201326.","journal-title":"Intensive Care Med"},{"key":"2209_CR52","doi-asserted-by":"crossref","unstructured":"Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months, later the story unfolds. Euro Surveill. 2016;21. https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2016.21.9.30155","DOI":"10.2807\/1560-7917.ES.2016.21.9.30155"},{"key":"2209_CR53","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2016.9690","volume":"316","author":"J Abbasi","year":"2016","unstructured":"Abbasi J. Infectious disease expert sees threat from colistin-resistant superbug. JAMA. 2016;316:806\u20137.","journal-title":"JAMA"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2209-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2209-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2209-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T22:58:44Z","timestamp":1605308324000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2209-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,28]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2209-4","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,28]]},"assertion":[{"value":"13 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original study was approved by the Human Ethics Committee of Lund University (LU 346\u201303), and the Local Ethical Review Board, Lund Sweden, which has replaced the former committee, approved the amendment for the present expansion. Informed consent was obtained from the patients or their next of kin.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All results are presented on a group basis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Probi AB provided the study product and performed bacterial analyses as an unconditional grant. Probi AB has also done the same in earlier studies conducted by BK. Probi AB holds the patent for the investigated bacterium, but there is no patent regarding the studied application.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"272"}}